Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Debt: 2020-2025

Historic Non-Current Debt for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $287.4 million.

  • Maravai Lifesciences Holdings' Non-Current Debt fell 44.34% to $287.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $287.4 million, marking a year-over-year decrease of 44.34%. This contributed to the annual value of $290.5 million for FY2024, which is 44.00% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Non-Current Debt stood at $287.4 million, which was down 0.37% from $288.4 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Non-Current Debt's 5-year high stood at $744.3 million during Q3 2021, with a 5-year trough of $287.4 million in Q3 2025.
  • Its 3-year average for Non-Current Debt is $449.4 million, with a median of $517.1 million in 2024.
  • In the last 5 years, Maravai Lifesciences Holdings' Non-Current Debt skyrocketed by 35.07% in 2022 and then slumped by 44.34% in 2025.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Non-Current Debt stood at $713.5 million in 2021, then fell by 26.84% to $522.0 million in 2022, then decreased by 0.63% to $518.7 million in 2023, then slumped by 44.00% to $290.5 million in 2024, then slumped by 44.34% to $287.4 million in 2025.
  • Its Non-Current Debt was $287.4 million in Q3 2025, compared to $288.4 million in Q2 2025 and $289.5 million in Q1 2025.